Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs sufentanil for analgesia during painless abortion
ChiCTR2000040243Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in abortion, Visceral pain, dysmenorrhea and 1 more comparing Sufentanil Group with Nalbuphine Group (2 arms). Primary endpoints: Intraoperative analgesic effect and Postoperative analgesic effect. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
abortionVisceral paindysmenorrheapropofol injection site pain (PISP)
Beyond the preview
Go deeper on ChiCTR2000040243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040243.